263 related articles for article (PubMed ID: 24390333)
1. A double-mimetic peptide efficiently neutralizes HIV-1 by bridging the CD4- and coreceptor-binding sites of gp120.
Quinlan BD; Joshi VR; Gardner MR; Ebrahimi KH; Farzan M
J Virol; 2014 Mar; 88(6):3353-8. PubMed ID: 24390333
[TBL] [Abstract][Full Text] [Related]
2. Adaptation of HIV-1 to cells with low expression of the CCR5 coreceptor.
Espy N; Pacheco B; Sodroski J
Virology; 2017 Aug; 508():90-107. PubMed ID: 28521215
[TBL] [Abstract][Full Text] [Related]
3. Activation and Inactivation of Primary Human Immunodeficiency Virus Envelope Glycoprotein Trimers by CD4-Mimetic Compounds.
Madani N; Princiotto AM; Zhao C; Jahanbakhshsefidi F; Mertens M; Herschhorn A; Melillo B; Smith AB; Sodroski J
J Virol; 2017 Feb; 91(3):. PubMed ID: 27881646
[TBL] [Abstract][Full Text] [Related]
4. Peptide ligands selected with CD4-induced epitopes on native dualtropic HIV-1 envelope proteins mimic extracellular coreceptor domains and bind to HIV-1 gp120 independently of coreceptor usage.
Dervillez X; Klaukien V; Dürr R; Koch J; Kreutz A; Haarmann T; Stoll M; Lee D; Carlomagno T; Schnierle B; Möbius K; Königs C; Griesinger C; Dietrich U
J Virol; 2010 Oct; 84(19):10131-8. PubMed ID: 20660187
[TBL] [Abstract][Full Text] [Related]
5. Peptides from second extracellular loop of C-C chemokine receptor type 5 (CCR5) inhibit diverse strains of HIV-1.
Dogo-Isonagie C; Lam S; Gustchina E; Acharya P; Yang Y; Shahzad-ul-Hussan S; Clore GM; Kwong PD; Bewley CA
J Biol Chem; 2012 Apr; 287(18):15076-86. PubMed ID: 22403408
[TBL] [Abstract][Full Text] [Related]
6. Characterization of Human Immunodeficiency Virus (HIV-1) Envelope Glycoprotein Variants Selected for Resistance to a CD4-Mimetic Compound.
Anang S; Richard J; Bourassa C; Goyette G; Chiu TJ; Chen HC; Smith AB; Madani N; Finzi A; Sodroski J
J Virol; 2022 Sep; 96(17):e0063622. PubMed ID: 35980207
[TBL] [Abstract][Full Text] [Related]
7. Position 22 of the V3 loop is associated with HIV infectivity.
Wei XM; Xu HF; Cheng XD; Bu N; Zhou HZ
Arch Virol; 2017 Mar; 162(3):637-643. PubMed ID: 27815696
[TBL] [Abstract][Full Text] [Related]
8. A tyrosine-sulfated CCR5-mimetic peptide promotes conformational transitions in the HIV-1 envelope glycoprotein.
Kwong JA; Dorfman T; Quinlan BD; Chiang JJ; Ahmed AA; Choe H; Farzan M
J Virol; 2011 Aug; 85(15):7563-71. PubMed ID: 21613393
[TBL] [Abstract][Full Text] [Related]
9. A Coreceptor-Mimetic Peptide Enhances the Potency of V3-Glycan Antibodies.
Fetzer I; Davis-Gardner ME; Gardner MR; Alfant B; Weber JA; Prasad NR; Zhou AS; Farzan M
J Virol; 2019 Mar; 93(5):. PubMed ID: 30541842
[TBL] [Abstract][Full Text] [Related]
10. Tyrosine-sulfated V2 peptides inhibit HIV-1 infection via coreceptor mimicry.
Cimbro R; Peterson FC; Liu Q; Guzzo C; Zhang P; Miao H; Van Ryk D; Ambroggio X; Hurt DE; De Gioia L; Volkman BF; Dolan MA; Lusso P
EBioMedicine; 2016 Aug; 10():45-54. PubMed ID: 27389109
[TBL] [Abstract][Full Text] [Related]
11. Chemokine receptor-usage of clinical HIV-1 isolates obtained from patients with HIV-1 infection in late clinical stages using PHA-blast.
Matsuda S; Miyata M
Microbiol Immunol; 1999; 43(10):967-74. PubMed ID: 10585143
[TBL] [Abstract][Full Text] [Related]
12. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
Hill CM; Deng H; Unutmaz D; Kewalramani VN; Bastiani L; Gorny MK; Zolla-Pazner S; Littman DR
J Virol; 1997 Sep; 71(9):6296-304. PubMed ID: 9261346
[TBL] [Abstract][Full Text] [Related]
13. Identification of determinants on a dualtropic human immunodeficiency virus type 1 envelope glycoprotein that confer usage of CXCR4.
Cho MW; Lee MK; Carney MC; Berson JF; Doms RW; Martin MA
J Virol; 1998 Mar; 72(3):2509-15. PubMed ID: 9499115
[TBL] [Abstract][Full Text] [Related]
14. Synthetic peptides for study of human immunodeficiency virus infection.
Dettin M; Scarinci C; Pasquato A; Di Bello C
Appl Biochem Biotechnol; 2002; 102-103(1-6):41-7. PubMed ID: 12396109
[TBL] [Abstract][Full Text] [Related]
15. Specific interaction of CCR5 amino-terminal domain peptides containing sulfotyrosines with HIV-1 envelope glycoprotein gp120.
Cormier EG; Persuh M; Thompson DA; Lin SW; Sakmar TP; Olson WC; Dragic T
Proc Natl Acad Sci U S A; 2000 May; 97(11):5762-7. PubMed ID: 10823934
[TBL] [Abstract][Full Text] [Related]
16. Alternative coreceptor requirements for efficient CCR5- and CXCR4-mediated HIV-1 entry into macrophages.
Cashin K; Roche M; Sterjovski J; Ellett A; Gray LR; Cunningham AL; Ramsland PA; Churchill MJ; Gorry PR
J Virol; 2011 Oct; 85(20):10699-709. PubMed ID: 21835796
[TBL] [Abstract][Full Text] [Related]
17. Binding thermodynamics of the N-terminal peptide of the CCR5 coreceptor to HIV-1 envelope glycoprotein gp120.
Brower ET; Schön A; Klein JC; Freire E
Biochemistry; 2009 Feb; 48(4):779-85. PubMed ID: 19170639
[TBL] [Abstract][Full Text] [Related]
18. Selected amino acid changes in HIV-1 subtype-C gp41 are associated with specific gp120(V3) signatures in the regulation of co-receptor usage.
Dimonte S; Babakir-Mina M; Mercurio F; Di Pinto D; Ceccherini-Silberstein F; Svicher V; Perno CF
Virus Res; 2012 Sep; 168(1-2):73-83. PubMed ID: 22732432
[TBL] [Abstract][Full Text] [Related]
19. Structural basis of coreceptor recognition by HIV-1 envelope spike.
Shaik MM; Peng H; Lu J; Rits-Volloch S; Xu C; Liao M; Chen B
Nature; 2019 Jan; 565(7739):318-323. PubMed ID: 30542158
[TBL] [Abstract][Full Text] [Related]
20. Roles of CD4 and coreceptors in binding, endocytosis, and proteolysis of gp120 envelope glycoproteins derived from human immunodeficiency virus type 1.
Kozak SL; Kuhmann SE; Platt EJ; Kabat D
J Biol Chem; 1999 Aug; 274(33):23499-507. PubMed ID: 10438529
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
